SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 39 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $237,703 | -52.1% | 141,000 | -45.1% | 0.02% | -51.4% |
| Q1 2023 | $496,500 | -40.1% | 257,000 | -42.1% | 0.04% | -34.0% |
| Q4 2022 | $829,392 | +112.1% | 444,000 | +88.9% | 0.05% | +103.8% |
| Q3 2022 | $391,000 | -97.5% | 235,000 | -96.3% | 0.03% | -97.7% |
| Q4 2020 | $15,722,000 | +18.2% | 6,412,000 | -0.1% | 1.12% | -2.3% |
| Q3 2020 | $13,306,000 | +12.2% | 6,418,000 | +24.2% | 1.15% | +10.6% |
| Q2 2020 | $11,858,000 | +159.4% | 5,167,000 | +71.7% | 1.04% | +157.6% |
| Q1 2020 | $4,572,000 | -38.2% | 3,009,000 | -20.9% | 0.40% | -18.1% |
| Q4 2019 | $7,397,000 | +46.9% | 3,803,000 | -0.2% | 0.49% | +34.1% |
| Q3 2019 | $5,034,000 | -39.8% | 3,810,000 | +1.5% | 0.37% | -40.9% |
| Q2 2019 | $8,356,000 | +22.7% | 3,754,000 | -0.5% | 0.62% | +8.9% |
| Q1 2019 | $6,808,000 | – | 3,772,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 61,662,000 | $127,669,000 | 4.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 94,165,000 | $195,054,000 | 1.73% |
| SSI INVESTMENT MANAGEMENT LLC | 6,418,000 | $13,306,000 | 1.15% |
| Opti Capital Management, LP | 3,625,000 | $7,517,000 | 0.92% |
| LINDEN ADVISORS LP | 32,702,000 | $67,675,000 | 0.82% |
| Verition Fund Management LLC | 14,948,000 | $31,032,000 | 0.62% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 11,418,000 | $23,673,000 | 0.52% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,000,000 | $10,382,000 | 0.40% |
| AQR Arbitrage LLC | 4,625,000 | $9,602,000 | 0.35% |
| Calamos Advisors LLC | 25,051,000 | $51,955,000 | 0.33% |